BioSpace News Archive

Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit

Scinai Immunotherapeutics Ltd. announced that the Israel Innovation Authority has approved a non-dilutive grant covering 66% of the costs of an ILS 3,536,939 project aimed at ramping up Scinai’s new CDMO business unit.

November 6, 2023
·
5 min read
Pharm Country

Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A’s Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced data was presented at Society of Immunotherapy of Cancer (SITC) 38th Annual Meeting on Saturday, November 4, 2023.

November 6, 2023
·
4 min read
Business

Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos’ Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care

Landmark Bio announced that it has signed a multi-year strategic manufacturing agreement with Galapagos NV (Euronext & NASDAQ: GLPG), an innovative biotech company with operations in Europe and the U.S.

November 6, 2023
·
3 min read
Genetown

Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States

Ardelyx, Inc. announced XPHOZAH is now available for shipment to partner pharmacies.

November 6, 2023
·
5 min read
BioCapital

I-Mab Announces Participation at Jefferies and Piper Conferences in November

I-Mab today announced its in-person participation in two conferences in November 2023, the Jefferies London Healthcare Conference and the Piper Sandler 35th Annual Healthcare Conference.

November 6, 2023
·
2 min read
Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023

Lunit is set to unveil seven significant abstracts at the Radiological Society of North America (RSNA) 2023 Annual Meeting, taking place from November 26 to November 30 in Chicago.

November 6, 2023
·
2 min read
Revance to Participate in Upcoming Investor Conferences - November 6, 2023

Revance Therapeutics, Inc. (RVNC), today announced that the company will be participating in the following investor conferences.

November 6, 2023
·
1 min read
Business

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

bioAffinity Technologies, Inc. today announced the appointment of Dallas J. Coleman as National Director of Sales.

November 6, 2023
·
5 min read
Drug Development

Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology

Equillium, Inc. today announced that data from the Type B portion of the EQUALISE study in lupus nephritis patients was presented at the annual meeting of the American Society of Nephrology (ASN).

November 6, 2023
·
9 min read
Business

Vistagen To Report Second Quarter Financial Results and Host Corporate Update Conference Call on November 9, 2023

Vistagen today announced it will host a conference call and webcast on Thursday, November 9, 2023, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 second quarter.

November 6, 2023
·
2 min read